Abpro ABP
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Abpro (ABP)
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
Key Insights
Critical company metrics and information
Latest Closing Price
$0.51Market Cap
$26.50 MillionTotal Outstanding Shares
51.97 Million SharesDividend
No dividendIPO Date
November 13, 2024SIC Description
Biological Products, (no Disgnostic Substances)Primary Exchange
NASDAQType
Common StockHeadquarters
6 st johns lane, floor 5, New york, NY, 10013Homepage
https://www.abpro.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Recent Headlines From The Web
Latest news, press releases, and media coverage about ABP from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.